Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adenosine and brain ischemia.

K A Rudolphi1, P Schubert, F E Parkinson

  • 1Hoechst AG Werk Kalle-Albert, Wiesbaden, Germany.

Cerebrovascular and Brain Metabolism Reviews
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein cysteine S-nitrosylation inhibits vesicular uptake of neurotransmitters.

Neuroscience·2015
Same author

Adenosine increases LPS-induced nuclear factor kappa B activation in smooth muscle cells via an intracellular mechanism and modulates it via actions on adenosine receptors.

Acta physiologica (Oxford, England)·2013
Same author

Inhibition of sodium-linked glucose reabsorption normalizes diabetes-induced glomerular hyperfiltration in conscious adenosine A₁-receptor deficient mice.

Acta physiologica (Oxford, England)·2013
Same author

Peripheral adenosine A2A receptors are involved in carrageenan-induced mechanical hyperalgesia in mice.

Neuroscience·2010
Same author

CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes.

Journal of neuroimmunology·2010
Same author

The birth and postnatal development of purinergic signalling.

Acta physiologica (Oxford, England)·2010
Same journal

Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions.

Cerebrovascular and brain metabolism reviews·1996
Same journal

Neuroimaging for differentiating vascular from Alzheimer's dementias.

Cerebrovascular and brain metabolism reviews·1996
Same journal

Opiate receptor-mediated mechanisms in the regulation of cerebral blood flow.

Cerebrovascular and brain metabolism reviews·1996
Same journal

Vascular dementia: a construct in evolution.

Cerebrovascular and brain metabolism reviews·1996
Same journal

Multimodal monitoring and assessment of cerebral haemodynamic reserve after severe head injury.

Cerebrovascular and brain metabolism reviews·1996
Same journal

Cortical thermal clearance as a predictor of imminent neurological deterioration.

Cerebrovascular and brain metabolism reviews·1996
See all related articles

Adenosine acts as a neuroprotective agent in brain ischemia by modulating adenosine receptors (A1 and A2). Enhancing adenosine signaling reduces ischemic brain damage, highlighting its therapeutic potential.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Ischemic Stroke Research

Background:

  • Adenosine is an endogenous nucleoside formed during ischemia from ATP breakdown.
  • It is released into the extracellular space, with significantly increased levels measured in brain areas during ischemic events.
  • Adenosine exerts its effects via A1 and A2 receptors found on various brain cells and blood components.

Purpose of the Study:

  • To investigate the neuroprotective role of adenosine in brain ischemia.
  • To explore the mechanisms underlying adenosine's effects on ischemic brain damage.
  • To evaluate the therapeutic potential of manipulating the adenosine system for stroke treatment.

Main Methods:

  • Utilized in vivo and in vitro models of brain ischemia.

Related Experiment Videos

  • Employed microdialysis to measure interstitial adenosine levels.
  • Investigated the effects of pharmacological agents targeting adenosine receptors (agonists, antagonists) and cellular reuptake/inactivation inhibitors.

    • Main Results:

    • Adenosine receptor antagonists exacerbated ischemic brain damage.
    • Adenosine receptor agonists and inhibitors of adenosine reuptake/inactivation demonstrated neuroprotection.
    • Chronic caffeine administration, a competitive antagonist, led to A1-receptor upregulation and attenuated damage.
    • Adenosine's protective mechanisms involve A1-mediated inhibition of excitatory neurotransmitter release and A2-mediated improvements in cerebral microcirculation.

    Conclusions:

    • Adenosine plays a critical neuroprotective role in brain ischemia.
    • Modulating adenosine signaling, particularly via A1 receptors, offers a promising therapeutic strategy for ischemic stroke.
    • The dual action of adenosine on neuronal function and cerebral blood flow underscores its multifaceted protective effects.